Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Dynamic changes of T-lymphocyte subsets and the correlations with 89 patients with coronavirus disease 2019
Mingxiang Huang1, Yao Wang1, Jing Ye1
1Fuzhou Pulmonary Hospital & Fujian Medical University Clinical Teaching Hospital, Fuzhou, China.
Insights
Peripheral T lymphocyte counts in COVID-19 patients decrease during acute infection, particularly in severe cases. Monitoring these T cells aids in predicting patient prognosis and immune function recovery.
Area of Science:
- Immunology
- Virology
- Clinical Medicine
Background:
- The global outbreak of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents a significant public health challenge.
- Understanding the immune response, particularly T lymphocyte dynamics, is crucial for managing COVID-19 pathogenesis and patient outcomes.
Purpose of the Study:
- To investigate the dynamic changes in peripheral blood T lymphocyte subsets in COVID-19 patients.
- To explore the role of these T cell subsets in COVID-19 pathogenesis and their impact on patient prognosis.
Main Methods:
- Flow cytometry was used to analyze peripheral blood T lymphocyte subsets (CD45+, CD3+, CD4+, CD8+) in 89 COVID-19 patients.
- Patients were categorized into moderate and severe/critical groups, and further into improved and unimproved outcomes.
- Results were compared between patient groups and a normal control group.
Main Results:
- COVID-19 patients exhibited decreased absolute counts of lymphocytes and T lymphocytes during the acute phase, most pronounced in the severe/critical group.
- T-lymphocyte counts in severe/critical patients reached a nadir around day 14, recovering in improved patients but remaining low or decreasing in unimproved patients.
- While CD4+/CD8+ ratios remained stable in improved patients, a drop in CD8+ T cells led to an elevated ratio in the unimproved group.
Conclusions:
- T lymphocyte counts and subset analysis serve as valuable indicators for monitoring immune function in COVID-19 patients.
- These immunological markers can effectively predict the prognosis of COVID-19 patients.
Background:
In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. The coronavirus has spread throughout the world, posing a severe threat to human health. By using flow cytometry, here we observed the dynamic changes of peripheral blood T lymphocyte subsets in COVID-19 patients, with an attempt to explore their roles in the pathogenesis of COVID-19 and their impacts on prognosis.
Methods:
Eighty-nine COVID-19 patients were divided into a moderate group (n=70) and the severe/critical group (n=19) according to the disease severity. Furthermore, the severe/critical patients were divided into the improved group (n=14) and unimproved group (n=5) according to the outcomes. The absolute peripheral blood lymphocytes counts and subsets, including CD45+, CD3+, CD4+, and CD8+, in the acute phase, and flow cytometry measured the recovery phase for all patients. Then, the results were compared with those in the normal control group.
Results:
The absolute counts of lymphocytes, T lymphocytes, and their subsets decreased during the acute phase in COVID-19 patients, especially in the severe/critical group. The T-lymphocyte count reached the lowest point on the 14th day in the severe/critical group. It rose with fluctuations to the normal level in the improved group as the immune function recovered; in the unimproved group, however, the T-lymphocyte count remained at a low level or even continued to decrease. The percentages of CD4+ and CD8+ T lymphocytes showed no visible change in the improved group; however, the percentage of CD8+ T cells dropped in the unimproved group, resulting in higher CD4+/CD8+ ratio.
Conclusions:
T lymphocytes count, and their subsets can be used for monitoring the immune functions and predicting the prognosis of COVID-19 patients.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell-mediated Immune Responses
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

